Weight loss as a predictor of survival and disease progression in HIV infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 1, 1998, Pages 80-85

  Wheeler, David A ^a,f,g   Gibert, Cynthia L ^b   Launer, Cynthia A ^c   Muurahainen, Norma ^d   Elion, Richard A ^b   Abrams, Donald I ^e   Bartsch, Glenn E ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Philadelphia Fight   (United States)

^e Community Consortium ^*  (United States)

^f Infectious Diseases Physicians Inc ^*  (United States)

^g Infectious Diseases Physicians Inc   (United States)

Author keywords

HIV; Opportunistic infection; Survival; Wasting; Weight loss

Indexed keywords

ARTICLE; CAUSE OF DEATH; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MYCOBACTERIUM INTRACELLULARE AVIUM; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; WEIGHT REDUCTION;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE; MYCOBACTERIUM INTRACELLULARE; PNEUMOCYSTIS CARINII; RNA VIRUSES;

EID: 0032080186     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199805010-00012     Document Type: Article

References (19)

1. Weiss PJ, Wallace MR, Olson PE, Rosetti R. Changes in the mix of AIDS defining conditions. N Engl J Med 1993;329:1962.
2. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993; 329:1922-6.
3. Nahlen BL, Chu SY, Nwanyanwu OC, Berkelman RL, Martinez SA, Rullan JV. HIV wasting syndrome in the United States. AIDS 1993;7:183-8.
4. Volberding P, Kaslow K, Bilk M. Prognostic factors in staging Kaposi's sarcoma in AIDS. Proc Am Soc Clin Oncol 1984;3:51.
5. Dworkin B, Wormser GP, Rosenthal WS. Gastrointestinal manifestations of the acquired immunodeficiency syndrome: a review of 22 cases. Am J Gastroenterol 1985;80:774-8.
6. McCorkindale C, Dybevik K, Coulston AM, Sucher KP. Nutritional status of HIV-infected patients during the early disease stages. J Am Diet Assoc 1990;90:1236-41.
7. Macallan DC, Noble C, Baldwin C, Foskett M, McManus T, Griffin GE. Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 1993; 58:417-24.
8. Kotler DP, Tierney AR, Culpepper-Morgan JA, Wang J, Pierson RN. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1990;14:454-8.
9. Kotler DP, Tierney AR, Wang J, Pierson RN. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
10. Palenicek JP, Graham NMH, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:366-73.
11. Jacobson MA, Besch CL, Child C, et al. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced HIV disease: results of a randomized trial. J Infect Dis 1994;169:384-94.
12. Abrams DI, Goldman AI, Launer C, et al. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. N Engl J Med 1994;330:657-2.
13. Saravolatz LD, Winslow DL, Collins G, et al. Zidovudine alone or in combination with didanosine or zalcitabine in HIV infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. N Engl J Med 1996;335: 1099-1106.
14. Brosgart C, Craig C, Hillman D, et al. Final results from a randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of CMV retinal and gastrointestinal mucosal disease [abstract Th.B.301]. Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, July, 1996.
15. Brozek J, Wells S, Keys A. Medical aspects of semistarvation in Leningrad (siege 1941-1942). Am Rev Soviet Med 1946;4:70-86.
16. Chlebowski RT, Grosvenor MB, Bernhard NH, Morales LS, Bulcanage LM. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 1989;84:1288-93.
17. Guenter P, Muurahainen N, Simons G, et al. Relationship among nutritional status, disease progression, and survival. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:1130-8.
18. Graham NMH, Munoz A, Bacellar H, Kingsley LA, Visscher BR, Phair JP. Clinical factors associated with weight loss related to infection with human immunodeficiency virus type 1 in the multicenter AIDS cohort study. Am J Epidemiol 1993;137:439-46.
19. Grunfeld C, Feingold KR. Body weight as essential data in the management of patients with human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Nutr 1993;58:317-8.